Arrowhead Pharmaceuticals
ARWR
41.37
-2.28
-5.22%
Arrowhead Pharmaceuticals
US · ARWR
#1569 by market cap
Listed 1970
41.37
-2.28
-5.22%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. Its drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
- Founded
- 1989
- CEO
- Dr. Christopher Anzalone,PhD
- Employees
- 711
- Headquarters
- Pasadena, California, United States of America
- Fiscal year end
- 09-30
- Website
- arrowheadpharma.com
Company profile
- Exchange
- US
- Symbol
- ARWR
- Market-cap rank
- #1569
- Listing date
- 1970-01-01
- Market cap
- 5.85B
- Float cap
- 5.08B
- Shares out
- 141.37M
- Float shares
- 122.91M
Sectors & themes
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Arrowhead Pharmaceuticals discussion 0 comments